|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | |
| A61K 38/22 | |||
| A61K 47/20 | |||
| A61K 9/19 | |||
| A61K 9/14 | |||
| A61K 38/28 |
| (11) | Patento numeris | 2773331 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12798470.6 |
| Europos patento paraiškos padavimo data | 2012-10-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-09-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-02-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/062816 |
| Data | 2012-10-31 |
| (87) | Numeris | WO 2013/067022 |
| Data | 2013-05-10 |
| (30) | Numeris | Data | Šalis |
| 201161553388 P | 2011-10-31 | US | |
| 201261609123 P | 2012-03-09 | US |
| (72) |
PRESTRELSKI, Steven, US
SCOTT, Nancy, US
|
| (73) |
Xeris Pharmaceuticals, Inc.,
3208 Red River, Suite 300, Austin TX 78705,
US
|
| (54) | FORMULATIONS FOR THE TREATMENT OF DIABETES |
| FORMULATIONS FOR THE TREATMENT OF DIABETES |